Lamb Weston Holdings, Inc. (LW) stock
Close on Nov 17, 2026Market cap $7.46BP/E 29.4Yield 2.77%
Earnings
Lamb Weston's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Lamb Weston's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2027ended Nov 23, 2026 | Dec 18, 2026Expected | – | – | – | – | – |
| Q1 FY2027ended Aug 30, 2026 | Oct 6, 2026before the open | $1.67B | +0.6% | $0.21 | $0.75 | Release |
| Q4 FY2026ended May 31, 2026 | Jul 24, 2026before the open | $1.77B | +5.6% | $0.79 | $0.87 | Release |
| Q3 FY2026ended Feb 22, 2026 | Apr 1, 2026before the open | $1.56B | +2.9% | $0.39 | $0.72 | Release |
| Q2 FY2026ended Nov 23, 2025 | Dec 19, 2025before the open | $1.62B | +1.1% | $0.44 | $0.69 | Release |
| Q1 FY2026ended Aug 24, 2025 | Sep 30, 2025before the open | $1.66B | +0.3% | $0.46 | $0.74 | Release |
| Q4 FY2025ended May 25, 2025 | Jul 23, 2025before the open | $1.68B | +4.0% | $0.85 | $0.87 | Release |
| Q3 FY2025ended Feb 23, 2025 | Apr 3, 2025before the open | $1.52B | – | $1.03 | $1.10 | Release |
| Q2 FY2025ended Nov 24, 2024 | Dec 19, 2024before the open | $1.60B | +9.8% | -$0.25 | $0.66 | Release |
| Q1 FY2025ended Aug 25, 2024 | Oct 2, 2024after the close | $1.65B | -4.5% | $0.88 | $0.73 | Release |
| Q4 FY2024ended May 26, 2024 | Jul 24, 2024before the open | $1.61B | -4.9% | $0.89 | $0.78 | Release |
| Q2 FY2024ended Feb 25, 2024 | Apr 4, 2024before the open | $1.46B | +16.3% | $1.01 | $1.20 | Release |
| Q1 FY2024ended Nov 26, 2023 | Jan 4, 2024before the open | $1.73B | +35.7% | $1.48 | $1.45 | Release |
| Q4 FY2023ended May 28, 2023 | Jul 25, 2023before the open | $1.70B | +47.0% | $3.40 | $1.22 | Release |
| Q2 FY2023ended Feb 26, 2023 | Apr 6, 2023before the open | $1.25B | +31.3% | $1.21 | $1.43 | Release |
| Q1 FY2023ended Nov 27, 2022 | Jan 5, 2023before the open | $1.28B | +26.8% | $0.71 | $1.28 | Release |
| Q4 FY2022ended May 29, 2022 | Jul 27, 2022before the open | $1.15B | – | $0.22 | $0.65 | Release |
| Q2 FY2022ended Feb 27, 2022 | Apr 7, 2022before the open | $955.00M | – | $0.73 | – | Release |
| Q1 FY2022ended Nov 28, 2021 | Jan 6, 2022before the open | $1.01B | – | $0.22 | $0.50 | Release |
| Q4 FY2021ended May 30, 2021 | Jul 27, 2021before the open | – | – | – | – | Filing |
| Q2 FY2021ended Feb 28, 2021 | Apr 7, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Nov 29, 2020 | Jan 7, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended May 31, 2020 | Jul 28, 2020before the open | – | – | – | – | Filing |
| Q2 FY2020ended Feb 23, 2020 | Apr 1, 2020before the open | – | – | – | – | Filing |
| Q1 FY2020ended Nov 24, 2019 | Jan 3, 2020before the open | – | – | – | – | Filing |
| Q4 FY2019ended May 26, 2019 | Jul 23, 2019before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Lamb Weston's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net Salesnon-GAAP | FY2027 | 0% – +1% | – | New | Jul 24, 2026 |
| Adjusted Income from Operationsnon-GAAP | FY2027 | $730.00M – $810.00M | $720.00M – $800.00M | Raised | Oct 6, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $1.13B – $1.22B | $1.10B – $1.20B | Raised | Oct 6, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2027 | $2.95 – $3.25 | – | New | Jul 24, 2026 |
| Capital Expenditures | FY2027 | $380.00M – $410.00M | – | New | Jul 24, 2026 |
| adjusted effective tax ratenon-GAAP | FY2027 | 25% – 27% | 25.5% – 27.5% | Lowered | Oct 6, 2026 |
| Depreciation and amortization expense | FY2027 | $410.00M | $410.00M | Raised | Oct 6, 2026 |
| Diluted outstanding common shares | FY2027 | 137.5 – 139 | 137.5 – 139 | Reaffirmed | Oct 6, 2026 |
| Interest expense, net | FY2027 | $185.00M – $190.00M | $190.00M | Lowered | Oct 6, 2026 |
| Net cash provided by operating activitiesGAAP | FY2027 | $750.00M – $800.00M | $750.00M – $800.00M | Reaffirmed | Oct 6, 2026 |
Guidance vs results
The last range Lamb Weston gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Revenue | $6.35B – $6.55B | $6.61BΣ4Q | Above range |
| FY2025 | Adjusted Diluted EPS | $3.05 – $3.20 | $3.36Σ4Q | Above range |
| FY2025 | Revenue | $6.35B – $6.45B | $6.45BΣ4Q | Within range |
| Q4 FY2024 | Revenue | $1.69B – $1.75B | $1.61B | Below range |
Guidance history
Every forecast Lamb Weston put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 6, 2026 | Adjusted EBITDA | FY2027 | $1.13B – $1.22B | Raised |
| Oct 6, 2026 | Adjusted Income from Operations | FY2027 | $730.00M – $810.00M | Raised |
| Oct 6, 2026 | Depreciation and amortization expense | FY2027 | $410.00M | Raised |
| Oct 6, 2026 | adjusted effective tax rate | FY2027 | 25% – 27% | Lowered |
| Oct 6, 2026 | Diluted outstanding common shares | FY2027 | 137.5 – 139 | Reaffirmed |
| Oct 6, 2026 | Net cash provided by operating activities | FY2027 | $750.00M – $800.00M | Reaffirmed |
| Oct 6, 2026 | Interest expense, net | FY2027 | $185.00M – $190.00M | Lowered |
| Jul 24, 2026 | Capital Expenditures | FY2027 | $380.00M – $410.00M | New |
| Jul 24, 2026 | Adjusted EBITDA | FY2027 | $1.10B – $1.20B | New |
| Jul 24, 2026 | Adjusted Diluted EPS | FY2027 | $2.95 – $3.25 | New |
| Jul 24, 2026 | Adjusted Income from Operations | FY2027 | $720.00M – $800.00M | New |
| Jul 24, 2026 | adjusted effective tax rate | FY2027 | 25.5% – 27.5% | New |
| Jul 24, 2026 | Diluted outstanding common shares | FY2027 | 137.5 – 139 | New |
| Jul 24, 2026 | Net cash provided by operating activities | FY2027 | $750.00M – $800.00M | New |
| Jul 24, 2026 | Interest expense, net | FY2027 | $190.00M | Lowered |
| Jul 24, 2026 | Depreciation and amortization expense | FY2027 | $410.00M | New |
| Jul 24, 2026 | Net Sales | FY2027 | 0% – +1% | New |
| Dec 19, 2025 | Cash Used for Capital Expenditures | FY2026 | $500.00M | Reaffirmed |
| Dec 19, 2025 | Adjusted EBITDA | FY2026 | $1.00B – $1.20B | Reaffirmed |
| Dec 19, 2025 | Net Sales | FY2026 | $6.35B – $6.55B | Reaffirmed |
| Sep 30, 2025 | Cash used for capital expenditures | FY2026 | $500.00M | Reaffirmed |
| Sep 30, 2025 | Adjusted EBITDA | FY2026 | $1.00B – $1.20B | Reaffirmed |
| Sep 30, 2025 | Net sales at constant currency | FY2026 | $6.35B – $6.55B | New |
| Jul 23, 2025 | Cash used for capital expenditures | FY2026 | $500.00M | New |
| Jul 23, 2025 | Adjusted EBITDA | FY2026 | $1.00B – $1.20B | New |
| Jul 23, 2025 | Net sales | FY2026 | $6.35B – $6.55B | New |
| Apr 3, 2025 | Cash used for capital expenditures, excluding acquisitions | FY2025 | $750.00M | New |
| Apr 3, 2025 | Adjusted EBITDA | FY2025 | $1.17B – $1.21B | New |
| Apr 3, 2025 | Adjusted Diluted EPS | FY2025 | $3.05 – $3.20 | New |
| Apr 3, 2025 | Adjusted Net Income | FY2025 | $440.00M – $460.00M | New |
| Apr 3, 2025 | Depreciation and amortization expense | FY2025 | $375.00M | New |
| Apr 3, 2025 | effective tax rate (full year) | FY2025 | 28% | New |
| Apr 3, 2025 | Adjusted SG&A | FY2025 | $665.00M – $675.00M | Raised |
| Apr 3, 2025 | Net sales | FY2025 | $6.35B – $6.45B | New |
| Dec 19, 2024 | Cash used for capital expenditures | FY2025 | $750.00M | Reaffirmed |
| Dec 19, 2024 | Adjusted EBITDA | FY2025 | $1.17B – $1.21B | Lowered |
| Dec 19, 2024 | Adjusted Diluted EPS | FY2025 | $3.05 – $3.20 | Lowered |
| Dec 19, 2024 | Diluted EPS | FY2025 | $2.30 – $2.45 | Lowered |
| Dec 19, 2024 | effective tax rate (full year) | FY2025 | 28% | New |
| Dec 19, 2024 | Adjusted SG&A | FY2025 | $680.00M – $690.00M | Raised |
| Dec 19, 2024 | Adjusted Net Income | FY2025 | $440.00M – $460.00M | Lowered |
| Dec 19, 2024 | GAAP net income | FY2025 | $330.00M – $350.00M | Lowered |
| Dec 19, 2024 | Depreciation and amortization expense | FY2025 | $375.00M | Reaffirmed |
| Dec 19, 2024 | net sales | FY2025 | $6.35B – $6.45B | New |
| Dec 19, 2024 | net sales | FY2025 | $3.10B – $3.20B | Lowered |
| Dec 19, 2024 | net sales growth | FY2025 | +1% – +4% | New |
| Oct 1, 2024 | cash used for capital expenditures | FY2025 | $750.00M | New |
| Oct 1, 2024 | Adjusted EBITDA | FY2025 | $1.38B – $1.48B | Reaffirmed |
| Oct 1, 2024 | Adjusted Diluted EPS | FY2025 | $4.15 – $4.35 | New |
| Oct 1, 2024 | Diluted EPS | FY2025 | $2.70 – $3.15 | Lowered |
| Oct 1, 2024 | depreciation and amortization expense | FY2025 | $375.00M | Raised |
| Oct 1, 2024 | Adjusted SG&A | FY2025 | $680.00M – $690.00M | Raised |
| Oct 1, 2024 | Adjusted Net Income | FY2025 | $600.00M – $615.00M | Lowered |
| Oct 1, 2024 | GAAP net income | FY2025 | $395.00M – $445.00M | Raised |
| Oct 1, 2024 | interest expense | FY2025 | $185.00M | New |
| Oct 1, 2024 | effective tax rate | FY2025 | 25% | New |
| Oct 1, 2024 | net sales | FY2025 | $6.60B – $6.80B | Reaffirmed |
| Jul 24, 2024 | Cash used for capital expenditures | FY2025 | $850.00M | New |
| Jul 24, 2024 | Adjusted EBITDA | FY2025 | $1.38B – $1.48B | New |
| Jul 24, 2024 | Diluted EPS | FY2025 | $4.35 – $4.85 | New |
| Jul 24, 2024 | Depreciation and amortization expense | FY2025 | $375.00M | Raised |
| Jul 24, 2024 | Interest expense | FY2025 | $180.00M | Lowered |
| Jul 24, 2024 | Net income | FY2025 | $630.00M – $705.00M | New |
| Jul 24, 2024 | Effective tax rate | FY2025 | 24% | New |
| Jul 24, 2024 | Adjusted SG&A | FY2025 | $740.00M – $750.00M | New |
| Jul 24, 2024 | Net sales growth | FY2025 | +2% – +5% | New |
| Jul 24, 2024 | Net sales | FY2025 | $6.60B – $6.80B | New |
| Apr 4, 2024 | Cash used for capital expenditures | FY2024 | $950.00M | Raised |
| Apr 4, 2024 | Adjusted EBITDA | FY2024 | $1.48B – $1.51B | Lowered |
| Apr 4, 2024 | Adjusted EBITDA | Q4 FY2024 | $350.00M – $375.00M | New |
| Apr 4, 2024 | Adjusted Diluted EPS | FY2024 | $5.50 – $5.65 | Lowered |
| Apr 4, 2024 | net sales | FY2024 | $6.54B – $6.60B | Lowered |
| Apr 4, 2024 | net sales | Q4 FY2024 | $1.69B – $1.75B | New |
| Jan 4, 2024 | Cash used for capital expenditures | FY2024 | $900.00M – $950.00M | Raised |
| Jan 4, 2024 | Adjusted EBITDA | FY2024 | $1.54B – $1.62B | Raised |
| Jan 4, 2024 | Adjusted Diluted EPS | FY2024 | $5.70 – $6.15 | New |
| Jan 4, 2024 | Diluted EPS | FY2024 | $5.70 – $6.15 | Raised |
| Jan 4, 2024 | interest expense | FY2024 | $140.00M | Lowered |
| Jan 4, 2024 | SG&A | FY2024 | $745.00M – $755.00M | Lowered |
| Jan 4, 2024 | effective tax rate | FY2024 | 23% – 24% | Reaffirmed |
| Jan 4, 2024 | GAAP net income | FY2024 | $830.00M – $900.00M | Raised |
| Jan 4, 2024 | Adjusted Net Income | FY2024 | $830.00M – $900.00M | New |
| Jan 4, 2024 | Depreciation and amortization expense | FY2024 | $305.00M | Raised |
| Jan 4, 2024 | net sales | FY2024 | $6.80B – $7.00B | New |
| Jul 25, 2023 | Cash used for capital expenditures | FY2024 | $800.00M – $900.00M | New |
| Jul 25, 2023 | Adjusted EBITDA including unconsolidated joint ventures | FY2024 | $1.45B – $1.53B | New |
| Jul 25, 2023 | Diluted EPS | FY2024 | $4.95 – $5.40 | New |
| Jul 25, 2023 | SG&A | FY2024 | $765.00M – $775.00M | Raised |
| Jul 25, 2023 | Net income | FY2024 | $725.00M – $790.00M | New |
| Jul 25, 2023 | Depreciation and amortization expense | FY2024 | $325.00M | Raised |
| Jul 25, 2023 | Interest expense | FY2024 | $165.00M | New |
| Jul 25, 2023 | Effective tax rate | FY2024 | 23% – 24% | New |
| Jul 25, 2023 | Net sales | FY2024 | $6.70B – $6.90B | New |
| Apr 6, 2023 | Cash used for capital expenditures | FY2023 | $700.00M – $725.00M | Raised |
| Apr 6, 2023 | Adjusted EBITDA including unconsolidated joint ventures | FY2023 | $1.18B – $1.21B | Raised |
| Apr 6, 2023 | Adjusted Diluted EPS | FY2023 | $4.35 – $4.50 | Raised |
| Apr 6, 2023 | Diluted EPS | FY2023 | $4.42 – $4.57 | Raised |
| Apr 6, 2023 | Gross margins including the consolidation of LW EMEA | FY2023 | 27% – 27.5% | Lowered |
| Apr 6, 2023 | Net income | FY2023 | $639.00M – $664.00M | Raised |
| Apr 6, 2023 | effective tax rate (full year), excluding items impacting comparability | FY2023 | 23% – 24% | Lowered |
| Apr 6, 2023 | SG&A, excluding items impacting comparability | FY2023 | $550.00M – $570.00M | Lowered |
| Apr 6, 2023 | Adjusted Net Income | FY2023 | $630.00M – $655.00M | Raised |
| Apr 6, 2023 | interest expense, net | FY2023 | $115.00M | Lowered |
| Apr 6, 2023 | Depreciation and amortization expense | FY2023 | $220.00M | Lowered |
| Apr 6, 2023 | Net sales | FY2023 | $5.25B – $5.35B | Raised |
| Jan 5, 2023 | Cash used for capital expenditures | FY2023 | $475.00M – $525.00M | Reaffirmed |
| Jan 5, 2023 | Adjusted EBITDA including unconsolidated joint ventures | FY2023 | $1.05B – $1.10B | Raised |
| Jan 5, 2023 | Adjusted Diluted EPS | FY2023 | $3.75 – $4.00 | New |
| Jan 5, 2023 | Diluted EPS | FY2023 | $4.03 – $4.28 | Raised |
| Jan 5, 2023 | Gross margins | FY2023 | 27% – 28% | Reaffirmed |
| Jan 5, 2023 | Gross margins | FY2023 | 27% – 28% | New |
| Jan 5, 2023 | Depreciation and amortization expense | FY2023 | $210.00M | Raised |
| Jan 5, 2023 | Interest expense, net | FY2023 | $115.00M | Lowered |
| Jan 5, 2023 | Net income | FY2023 | $580.00M – $620.00M | Raised |
| Jan 5, 2023 | Effective tax rate | FY2023 | 24% | New |
| Jan 5, 2023 | SG&A, excluding items impacting comparability | FY2023 | $525.00M – $550.00M | Lowered |
| Jan 5, 2023 | Adjusted Net Income | FY2023 | $540.00M – $580.00M | New |
| Jan 5, 2023 | Net sales | FY2023 | $4.80B – $4.90B | Raised |
| Jul 27, 2022 | Cash used for capital expenditures | FY2023 | $475.00M – $525.00M | New |
| Jul 27, 2022 | Adjusted EBITDA including unconsolidated joint ventures (1) | FY2023 | $840.00M – $910.00M | New |
| Jul 27, 2022 | Diluted EPS | FY2023 | $2.45 – $2.85 | New |
| Jul 27, 2022 | gross margins | FY2023 | 25% – 26% | New |
| Jul 27, 2022 | Net income | FY2023 | $360.00M – $410.00M | New |
| Jul 27, 2022 | Depreciation and amortization expense | FY2023 | $210.00M | Raised |
| Jul 27, 2022 | Interest expense | FY2023 | $115.00M | Lowered |
| Jul 27, 2022 | SG&A | FY2023 | $475.00M – $500.00M | Raised |
| Jul 27, 2022 | Effective tax rate (2) (full year) | FY2023 | 24% | New |
| Jul 27, 2022 | Net sales | FY2023 | $4.70B – $4.80B | New |
| Apr 7, 2022 | cash used for capital expenditures, excluding acquisitions | FY2022 | $325.00M | Lowered |
| Apr 7, 2022 | gross margin | FY2022 | 19% – 20% | New |
| Apr 7, 2022 | gross margin | Q4 FY2022 | 19% – 21% | New |
| Apr 7, 2022 | Depreciation and amortization | FY2022 | $190.00M | Raised |
| Apr 7, 2022 | Effective tax rate | FY2022 | 22% | Reaffirmed |
| Apr 7, 2022 | Interest expense | FY2022 | $163.00M | Lowered |
| Jan 6, 2022 | Cash used for capital expenditures, excluding acquisitions | FY2022 | $450.00M | New |
| Jan 6, 2022 | gross margin | FY2022 | 18% – 20% | New |
| Jan 6, 2022 | Depreciation and amortization | FY2022 | $190.00M | New |
| Jan 6, 2022 | Income tax expense | FY2022 | 22% | New |
| Jan 6, 2022 | interest expense, net | FY2022 | $163.00M | Lowered |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Lamb Weston filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Update
See a number that looks wrong?